A Pre-Approval Information Exchange (PIE) Webinar, presented by Astellas 

Pre-approval information exchange sharing GATHER2 Year 2 Avacincaptad pegol (ACP) intravitreal solution safety and efficacy data and an overview of Geographic Atrophy. 

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®. 

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP Webinar, hosted by FormularyDecisions 

Please join us for an interactive session exploring artificial intelligence (AI)’s applications and limitations in the realm of evidence generation strategies. In this session, we will review insights from healthcare decision makers on AI adoption within their organizations. Additionally, our expert panelists will explore opportunities to mitigate concerns about AI acceptance and hesitation in today’s complex landscape. Using real-world case studies, we will also share how AI can be used to improve efficiencies in aggregating data and communicating evidence. 

Who should attend? Team members across the biopharma industry, managed care professionals, and other new and seasoned learners across healthcare can benefit from panelist insights and perspectives. Join us for an engaging discussion and unlock AI’s capabilities and potential in accelerating innovation! Register today to secure your spot!

 Learning Objectives: 

1. Review market research insights on AI adoption and perceptions among healthcare decision makers. 
2. Examine current capabilities and limitations of AI-powered tools. 
3. Identify best practices for the practical application of AI in health evidence generation strategy. 
4. Discuss trends and future opportunities to accelerate the trajectory of AI in an evolving landscape.

Unlock exclusive insights from the esteemed judges of the P&T Competition Finalist judges! Join us for this unique opportunity to learn directly from the experts who evaluate finalist submissions. 

Topics: 

• Monographs 
• PowerPoint Presentations 
• Live Presentations

A webinar sponsored by Sanofi.

1. Understand RSV Burden in US infants and review RSV epidemiology. 
2. Review the pivotal nirsevimab clinical development studies establishing safety and efficacy and supporting ACIP recommendations. 
3. Discuss global real-world data for nirsevimab efficacy, effectiveness and impact on RSV outcomes and nirsevimab safety. 
4. Implementing Optimal Immunization Strategies to Help Reduce RSV LRTI

This webinar is only offered to payers, formulary committees, or other similar entities responsible for selecting drugs for coverage or reimbursement. To join this webinar, you must be registered as a user of FormularyDecisions®.